ArticleAdvances in therapy2024

Survival Improvement of Stage IV Non-small Cell Lung Cancer in the Immunotherapy Era: A Retrospective Cohort Study in a US Population.

Lianfang Ni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.